Ichikawa, T.; Shibata, M.; Inaishi, T.; Soeda, I.; Kanda, M.; Hayashi, M.; Takano, Y.; Takeuchi, D.; Tsunoda, N.; Kodera, Y.;
et al. Synaptotagmin 13 Is Highly Expressed in Estrogen Receptor-Positive Breast Cancer. Curr. Oncol. 2021, 28, 4080-4092.
https://doi.org/10.3390/curroncol28050346
AMA Style
Ichikawa T, Shibata M, Inaishi T, Soeda I, Kanda M, Hayashi M, Takano Y, Takeuchi D, Tsunoda N, Kodera Y,
et al. Synaptotagmin 13 Is Highly Expressed in Estrogen Receptor-Positive Breast Cancer. Current Oncology. 2021; 28(5):4080-4092.
https://doi.org/10.3390/curroncol28050346
Chicago/Turabian Style
Ichikawa, Takahiro, Masahiro Shibata, Takahiro Inaishi, Ikumi Soeda, Mitsuro Kanda, Masamichi Hayashi, Yuko Takano, Dai Takeuchi, Nobuyuki Tsunoda, Yasuhiro Kodera,
and et al. 2021. "Synaptotagmin 13 Is Highly Expressed in Estrogen Receptor-Positive Breast Cancer" Current Oncology 28, no. 5: 4080-4092.
https://doi.org/10.3390/curroncol28050346
APA Style
Ichikawa, T., Shibata, M., Inaishi, T., Soeda, I., Kanda, M., Hayashi, M., Takano, Y., Takeuchi, D., Tsunoda, N., Kodera, Y., & Kikumori, T.
(2021). Synaptotagmin 13 Is Highly Expressed in Estrogen Receptor-Positive Breast Cancer. Current Oncology, 28(5), 4080-4092.
https://doi.org/10.3390/curroncol28050346